Movianto UK expands cold chain and controlled drugs storage

Published: 22-Jun-2011
Packaging Logistics

Doubles cold storage capacity to 4,500 pallet spaces

Movianto UK, a healthcare logistics specialist, has made a ‘substantial investment’ in the expansion of its cold chain and controlled drug facilities in Bedford.

Financial details have not been revealed, but the company, which has eight depots across the UK, says it has doubled its cold storage capacity to 4,500 pallet spaces in time for the procurement period as stocking starts in the late summer.

Movianto has also installed a temperature-controlled loading, unloading and packing facility.

In addition the company says it has more than doubled its narcotics storage in Bedford, which allows it to transport the drugs safely throughout mainland UK.

Movianto has added new manufacturing services, including the kitting, relabelling and repackaging of medications.

Russell Atkinson, Movianto’s managing director, said: ‘Our continued investment in the UK demonstrates our commitment to the market and our understanding of the future needs of the industry.’

See more

You may also like

Logistics

Davies & Robson maximises efficiency at Movianto\'s Bedford warehouse

Read more
Creates space for two new customers to be integrated into the facility

Trending Articles

  1. Sharp appoints Samantha Wilson Jones as General Counsel Sharp Services has appointed Samantha Wilson Jones as General Counsel and Corporate Secretary of Sharp
  2. Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial manufacturing network to meet growing pharmaceutical demand
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    From approval to access: the strategic role of packaging in drug launch success In today’s increasingly complex pharmaceutical landscape, securing regulatory approval is only one milestone on the journey to market
  4. Aenova Group In Europe and worldwide, Aenova is one of the leading contract development and manufacturing organisations (CDMO). The range of services covers the entire value chain of development and production of all common dosage forms (solid, semi-solid and liquid, sterile and non-sterile; high potency and low dosage) and product groups in drugs and food supplements for human and animal health
  5. Almac Group The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally

You may also like

Logistics

Davies & Robson maximises efficiency at Movianto\'s Bedford warehouse

Creates space for two new customers to be integrated into the facility
Sustainability

Movianto UK helps GSK expand inhaler-recycling scheme nationwide

Reduces number of inhalers being sent to landfill for disposal
Logistics

Movianto opens European distribution centre

For temperature-controlled storage of pharmaceuticals
Logistics

Movianto expands European logistics for Daiichi Sankyo

The logistics firm will undertake diverse specialised services along the supply chain
Media

Movianto opens subsidiary in the Netherlands

<p>Movianto, a Europe-wide logistics service provider for the pharmaceutical and healthcare industry, is expanding its presence in Benelux by opening a subsidiary in the Netherlands.</p>
Manufacturing

OPTIMA machinery USA Corporation marks 40 years of growth and innovation in the US

OPTIMA machinery USA Corporation, a subsidiary of the German-based OPTIMA Packaging Group, is celebrating 40 years of successful operations in the United States
Packaging

Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe

The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial manufacturing network to meet growing pharmaceutical demand
Subscribe now